I can help with that. NCT04512345 is a ClinicalTrials.gov identifier. I don’t have live access to ClinicalTrials.gov in this chat, but I can tell you exactly what to look for and how to interpret it. If you paste the trial page text or give me permission to fetch live data, I can summarize precisely.
What you’ll typically find for a trial involving aminolevulinic acid hydrochloride (5-ALA HCl)
- Official title and brief summary
- Condition or disease being studied
- Study type: Interventional (drug) or Observational
- Primary and secondary purpose (what the study aims to evaluate)
- Intervention details: aminolevulinic acid hydrochloride (dose, route, schedule), any combinations or comparators
- Phase (e.g., Phase I, II, III, or IV) and masking/randomization details
- Enrollment: number of participants
- Start and completion dates
- Locations and sites
- Sponsor and collaborators
- Eligibility criteria (inclusion/exclusion)
- Primary and secondary outcome measures
- Status: Not yet recruiting, Recruiting, Active, Not Recruiting, Completed, Terminated, etc.
- Contacts and sponsorship information
- Results (if the study is completed and results have been posted)
General notes about aminolevulinic acid hydrochloride (5-ALA HCl) in trials
-用途: 5-ALA HCl is used as a prodrug in photodynamic and fluorescence-guided procedures (e.g., tumor imaging during surgery, and investigated in other cancers). In some contexts it’s known as a fluorescent agent that helps visualize tumor tissue.
- Common safety considerations: photosensitivity/phototoxicity after dosing (patients may need to avoid bright light for a period), nausea or allergic-type reactions in some trials, and porphyria is typically a contraindication.
- Typical trial themes: dose-finding, safety/tolerability, imaging-guided surgery applications, diagnostic/therapeutic combinations, and comparisons to standard care or other imaging agents.
How I can help next
- If you want the exact details for NCT04512345, provide either:
- The live page text (copy-paste), or
- Give me permission to “browse” and I’ll pull the current ClinicalTrials.gov entry and summarize it.
- If you already have the page open, share the key fields you’re curious about (e.g., status, primary outcome, phase, sites), and I’ll explain what they mean and how to interpret them.
Would you like me to fetch and summarize the current details for NCT04512345 (with your go-ahead to access live data), or would you prefer you paste the page content here?